Method·September 23, 2026 · 3 min read

Two names on one registration, two jobs

Every foreign device establishment's FDA registration carries two separate named contacts, not one — a U.S. Agent FDA can legally treat as standing in for the firm itself, and an Official Correspondent who is simply who filed the form. The public record keeps both. Reading them as the same person misreads who FDA is actually allowed to rely on.

By Connor Griggs — Regulatory & Quality Strategist

A foreign device establishment’s registration record — on FDA’s own site, and in openFDA’s copy of it — carries two named people, not one. They are easy to read as the same contact wearing two hats. FDA’s own rule gives only one of them a power the other doesn’t have, and the record itself keeps them in separate fields for exactly that reason.

The one FDA can legally treat as the firm

21 CFR 807.40 requires every foreign establishment that manufactures, prepares, or processes a device imported into the United States to name a United States Agent as part of its registration — one agent per establishment, residing or maintaining a place of business here. On FDA’s request, the agent assists FDA in communicating with the foreign establishment, answers questions about the establishment’s imported products, and helps schedule inspections. The clause that matters most sits at the end of the rule: when FDA cannot reach the foreign establishment directly or expeditiously, the agency may hand information or documents to the U.S. Agent instead, and that delivery counts as delivery to the foreign establishment itself. The agent is not a courtesy contact. It is a legal stand-in FDA can use.

The one who actually filed the form

A separate role, the Official Correspondent, is the person a registrant authorizes to submit its registration and listing data and to handle FDA communications about that filing specifically. A firm is free to name the same person as both its U.S. Agent and its Official Correspondent — a common setup — or to split the two across different people entirely. Nothing in Part 807 gives the Official Correspondent, acting only in that capacity, the equivalent-delivery power 807.40 gives the U.S. Agent. Filing the paperwork and standing in for the firm are two different grants of authority, and holding the first doesn’t confer the second.

The record keeps the split

openFDA’s own field reference for the registration and listing dataset carries the distinction as separate, named fields rather than one contact block: registration.us_agent holds the U.S. Agent’s individual name, business name, and address, and a separate set of official-correspondent fields — first name, last name, phone, company — holds the other. Two people, in two fields, on one establishment record. A lookup that surfaces only one name, or that treats whichever name appears first as “the contact,” is reading half the record FDA actually publishes.

The practice

Reading a foreign competitor’s or a foreign supplier’s registration record, check which of the two fields a name sits in before treating it as the establishment’s point of contact. Only the name in the U.S. Agent field carries FDA’s equivalent-delivery authority under 807.40 — the Official Correspondent doesn’t inherit that power just by having a name on the same filing. Per what we monitor and how often, this is regulatory intelligence and method for reading a public registration record, never regulatory advice about who a specific establishment should designate for either role — that decision belongs with the firm and its own regulatory counsel.

Practice
A missed MDR is misbranding, not a defect
Practice
A K-number is public. The other isn't.
Method
Exempt covers the type, not the use
Method
Recognized. Not published.
Practice
The supplement got eSTAR. The PMA did not.
Method
Congress ordered a guidance, not a rule
Practice
AI-enabled is a list. Not a field.
Practice
The companion diagnostic list changed its name
Method
The master file neither of you can read
Practice
The condition inside the approval order
Method
The repair FDA calls manufacturing
Method
Vacated in March. Filed in September.
Practice
Classified. Not waived.
Practice
Emergency use isn't defined in Part 812
Method
The two-year inspection clock is gone
Method
The PMA clock starts at the last module
Practice
The Q-Sub that doesn't buy you more time
Method
Lapsed and revoked end an EUA differently
Practice
A recall strategy has a grade. openFDA doesn't.
Method
A granted De Novo becomes a predicate.
Practice
Least burdensome changes the ask, not the bar.
Method
The lab is accredited. Not the device.
Practice
Breakthrough is law. STeP is a guidance.
Practice
MDSAP replaces routine. Not for-cause.
Method
No field on a 510(k) says what it treats
Method
Discretion is a policy. Exclusion is a statute.
Practice
Designated by one office. Approved by another.
Method
MedSun sits beside MAUDE, not inside it
Practice
The five-unit device never gets a K-number
Practice
Meeting the criteria isn't a tracking order
Method
The PMA clock doesn't stop at approval
Practice
The K-number doesn't track today's device
Method
A MAUDE report proves it was filed
Practice
Not every MDR starts with the manufacturer
Method
Completed. Not terminated.
Practice
The device-ban list has three entries
Method
The UDI exception has its own deadline
Method
MDUFA VI is being negotiated in public
Practice
The inspection manual changed, not the rule
Method
The count Congress had to legislate
Practice
The small-business rate isn't retroactive
Method
A detention order has no docket to read
Practice
PMA approvals moved off the Federal Register
Method
A citizen petition names names
Practice
A market withdrawal isn't a recall
Method
Not every device letter comes from CDRH
Practice
Closed on one device. Open on the rest.
Method
No IDE is confirmed until the PMA is
Practice
The remedial-action call sets the clock
Method
Jurisdiction is a letter, not a field
Practice
An address is not a footprint
Method
The final rule that isn't final yet
Practice
The special controls aren't in the record
Method
Exempt from GMP. Not from complaints.
Practice
The notify list isn't the shortage list
Method
A constraint can't be skipped. A script can.
Practice
No cron sends this. A person does.
Method
Corrected, not rewritten
Practice
Quiet is a finding, not a default
Method
The summary is public. The statement isn't.
Practice
A competitor's 513(g) leaves no trace
Practice
An empty response field proves nothing
Method
A petition is public. Its outcome isn't.
Practice
The panel is a category, not a meeting
Method
An accessory carries its own classification
Method
A TPLC report is a category, not a device
Practice
A 522 order is a question, not a verdict
Method
A PCCP change leaves no new record
Practice
Not every signal becomes a recall
Method
eSTAR did not remove the acceptance check
Practice
An early alert has no recall number yet
Practice
A consent decree isn't a database row
Method
The record has no cybersecurity field
Practice
Classification Change is not one event
Method
Publication date is not effective date
Method
One event. Many recall numbers.
Practice
Quantity is a sentence, not a number
Practice
How a firm told you is a field too
Method
A RIN outlives the document number
Method
The docket ID is not the comments
Practice
The 510(k) record doesn't name the predicate
Practice
The 510(k) FDA didn't review first
Method
The letter FDA doesn't have to post
Practice
Cleared doesn't say which track it took
Method
The clock stops. The calendar doesn't.
Method
Why a guessed match never reaches you
Practice
The standards list never names a device
Method
The guidance isn't in the Federal Register.
Practice
Filtered. Not discarded.
Method
There are two recall databases, not one
Practice
Breakthrough status is confidential by law
Practice
One MAUDE report is not one malfunction
Method
A supplement number is not a track
Method
Cleared is not approved
Practice
Nationwide doesn't mean your building
Practice
Not every correction reaches FDA
Method
Registered. Not reviewed.
Method
Contact ODE is not a pathway
Practice
Almost no recall is FDA-mandated
Method
FDA's device names read like a card catalog
Practice
openFDA is free. It is not unlimited.
Method
GUDID stores the model. Not the box.
Practice
Detention doesn't need a warning letter
Method
A Class I device, a Class I recall
Practice
21 CFR 820 didn't move. Its contents did.
Method
The product code that doesn't exist yet
Practice
The classification posts. The 483 behind it doesn't.
Method
A recall has three dates, and the pipeline had to pick one
Practice
The count is real. The rate is not.
Method
The firm on the record is not the firm on the box
Practice
Low confidence is an instruction, not a hedge
Method
The same company, spelled three ways
Practice
A device that was never a medical device
Method
FDA's warning letters, addressed by column number
Practice
Your regulation has a decimal. FDA's watch doesn't.
Method
Three letters is too short to search for
Practice
Most warning letters never close
Method
The guidance that skipped the draft
Practice
Ongoing, as of when?
Method
The least interesting fact in a 510(k)
Practice
No recall arrives with a product code attached
Practice
The deadline that doesn't email you
Method
The warning letter has two dates
Method
How to monitor FDA without drowning
Practice
Your predicate was recalled. Now what?
Method
Why no item reaches you without a human